ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma

ClinicalTrials.gov ID: NCT00058370

Public ClinicalTrials.gov record NCT00058370. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 13, 2026, 9:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Trial Of Radioimmunotherapy, Reduced-Dose External Beam Craniospinal Radiation Therapy With IMRT Boost, And Chemotherapy For Patients With Standard-Risk Medulloblastoma

Study identification

NCT ID
NCT00058370
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Memorial Sloan Kettering Cancer Center
Other
Enrollment
6 participants

Conditions and interventions

Interventions

  • adjuvant therapy Procedure
  • cisplatin Drug
  • iodine I 131 monoclonal antibody 3F8 Radiation
  • lomustine Drug
  • radiation therapy Radiation
  • vincristine sulfate Drug

Procedure · Drug · Radiation

Eligibility (public fields only)

Age range
3 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2003
Primary completion
May 31, 2019
Completion
May 31, 2019
Last update posted
May 10, 2020

2003 – 2019

United States locations

U.S. sites
2
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York New York 10032
Memorial Sloan-Kettering Cancer Center New York New York 10065

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00058370, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 10, 2020 · Synced May 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00058370 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →